<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:sdc="http://www.alacra.com/sdc" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>I-FLOW Corporation RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>I-FLOW Corporation</description>
<link>http://www.alacrastore.com/company-snapshot/I_FLOW_Corporation-1026686</link>
<lastBuildDate>Monday, September 08, 2008 1:17:22 PM</lastBuildDate>
<alacra:xlsid>1026686</alacra:xlsid>
<alacra:company>I-FLOW Corporation</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><title>I-Flow Corp intends a stock buyback</title><description>US - In August ####, the board of I-Flow Corp (IC), a manufacturer of ambulatory drug delivery systems, authorized the repurchase of up to # mil common shares, or about #.###% of the company's common stock outstanding, in open market or privately negotiated transactions. Based on IC's closing stock price of $#.## on August ##, the last full trading day prior to the announcement of the board's approval, the buyback had an indicated value of up to $#.## mil.</description><pubDate>8/14/2008 10:31:36 AM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">449520</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">449520</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">449520</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">449520</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">I-Flow Corp</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">I-Flow Corp</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">I-Flow Corp</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">I-Flow Corp</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/I_Flow_Corp_intends_a_stock_buyback-2004175020</link><guid isPermaLink="false">sdc/2004175020</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>2004175020</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:a_EXCHANGE><sdc:a_MAINDUSTRY><sdc:value>Measuring, Medical, Photo Equipment; Clocks</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>United States</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Surgical and medical instruments and apparatus</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>3841</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>CA</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>California</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Public</sdc:value></sdc:a_STATUS><sdc:a_TICKER><sdc:value>IFLO</sdc:value></sdc:a_TICKER><sdc:asic_SIC><sdc:value>3841:Surgical and medical instruments and apparatus</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value>3841:Surgical and medical instruments and apparatus</sdc:value></sdc:aupsic_SIC><sdc:b_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:b_EXCHANGE><sdc:b_MAINDUSTRY><sdc:value>Measuring, Medical, Photo Equipment; Clocks</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>United States</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Surgical and medical instruments and apparatus</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>3841</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>CA</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>California</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Public</sdc:value></sdc:b_STATUS><sdc:b_TICKER><sdc:value>IFLO</sdc:value></sdc:b_TICKER><sdc:c_ACIDGEN><sdc:value>131259001</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Mnfr drug infusion sys</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Mnfr drug infusion sys</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value sdc:p="0">Cash</sdc:value><sdc:value sdc:p="1">Cash Only</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Common Stock</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>131259001</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>Aug 14 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>47.77100</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>-6.19600</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>-6.43200</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>-3.78600</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>-11.17300</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>-0.09600</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>132.91600</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.17500</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>-8.43500</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>-0.70000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>-15.80800</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>-18.45700</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>126.82400</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>161.12100</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_AEPS><sdc:value>0.00000</sdc:value></sdc:fiscal_AEPS><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_DATEFIN><sdc:value>30 Jun 08</sdc:value></sdc:fiscal_DATEFIN><sdc:fiscal_FISCAL><sdc:value>31 Dec 07</sdc:value></sdc:fiscal_FISCAL><sdc:fiscal_FISCAL1><sdc:value>31 Dec 06</sdc:value></sdc:fiscal_FISCAL1><sdc:fiscal_FISCAL2><sdc:value>31 Dec 05</sdc:value></sdc:fiscal_FISCAL2><sdc:fiscal_FISCAL3><sdc:value>31 Dec 04</sdc:value></sdc:fiscal_FISCAL3><sdc:fiscal_FISCAL4><sdc:value>31 Dec 03</sdc:value></sdc:fiscal_FISCAL4><sdc:fiscal_RATE><sdc:value>1.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">I-Flow Corp, located in Lake</sdc:value><sdc:value sdc:p="1">Forest, California,</sdc:value><sdc:value sdc:p="2">manufactures technically</sdc:value><sdc:value sdc:p="3">advanced, low-cost ambulatory</sdc:value><sdc:value sdc:p="4">drug delivery systems that</sdc:value><sdc:value sdc:p="5">provide life enhancing, cost</sdc:value><sdc:value sdc:p="6">effective solutions for pain</sdc:value><sdc:value sdc:p="7">management and infusion</sdc:value><sdc:value sdc:p="8">therapy. The company was</sdc:value><sdc:value sdc:p="9">founded in 1985.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value sdc:p="0">I-Flow Corp, located in Lake Forest, California,</sdc:value><sdc:value sdc:p="1">manufactures technically advanced, low-cost ambulatory drug</sdc:value><sdc:value sdc:p="2">delivery systems that provide life enhancing, cost effective</sdc:value><sdc:value sdc:p="3">solutions for pain management and infusion therapy. The</sdc:value><sdc:value sdc:p="4">company was founded in 1985.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>I-Flow Corp, located in Lake Forest, California, manufactures technically advanced, low-cost ambulatory drug delivery systems that provide life enhancing, cost effective solutions for pain management and infusion therapy. The company was founded in 1985.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">I-Flow Corp, located in Lake</sdc:value><sdc:value sdc:p="1">Forest, California,</sdc:value><sdc:value sdc:p="2">manufactures technically</sdc:value><sdc:value sdc:p="3">advanced, low-cost ambulatory</sdc:value><sdc:value sdc:p="4">drug delivery systems that</sdc:value><sdc:value sdc:p="5">provide life enhancing, cost</sdc:value><sdc:value sdc:p="6">effective solutions for pain</sdc:value><sdc:value sdc:p="7">management and infusion</sdc:value><sdc:value sdc:p="8">therapy. The company was</sdc:value><sdc:value sdc:p="9">founded in 1985.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">I-Flow Corp, located in Lake Forest, California,</sdc:value><sdc:value sdc:p="1">manufactures technically advanced, low-cost ambulatory drug</sdc:value><sdc:value sdc:p="2">delivery systems that provide life enhancing, cost effective</sdc:value><sdc:value sdc:p="3">solutions for pain management and infusion therapy. The</sdc:value><sdc:value sdc:p="4">company was founded in 1985.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>I-Flow Corp, located in Lake Forest, California, manufactures technically advanced, low-cost ambulatory drug delivery systems that provide life enhancing, cost effective solutions for pain management and infusion therapy. The company was founded in 1985.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>0.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>0.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>24.61000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>N</sdc:value></sdc:i_CROSS1><sdc:i_CURRENCYLONG><sdc:value>U.S. Dollar</sdc:value></sdc:i_CURRENCYLONG><sdc:i_DATEANN><sdc:value>12 Aug 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Tue, 12 Aug 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 08/12/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFFS><sdc:value>Date Effective:</sdc:value></sdc:i_DATEEFFS><sdc:i_DESCR><sdc:value>Buyback</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Not Appl.</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>0.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>0.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>-47.77100</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>9.72000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>9.72 U.S. Dollar</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>9.72000</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>239.17700</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>9.72 U.S. Dollar</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>9.72000</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>0.00000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>0.00000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>9.72000</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>9.72000</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>0.00000</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>9.72 U.S. Dollar</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>1.00000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>5.12800</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>0.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>0.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>9.72000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>9.72000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>5.66300</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>3.02200</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>-0.37700</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>0.00000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>4.06400</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>-28.35500</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>1.79900</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>-15.13000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>1.88600</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>-1.15200</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>-15.13000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>1.88600</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>132.91600</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>49.02900</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>36.53100</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value><sdc:value sdc:p="15">16.00000</sdc:value><sdc:value sdc:p="16">17.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">US - In August 2008, the board</sdc:value><sdc:value sdc:p="1">of I-Flow Corp (IC), a</sdc:value><sdc:value sdc:p="2">manufacturer of ambulatory</sdc:value><sdc:value sdc:p="3">drug delivery systems,</sdc:value><sdc:value sdc:p="4">authorized the repurchase of</sdc:value><sdc:value sdc:p="5">up to 1 mil common shares, or</sdc:value><sdc:value sdc:p="6">about 4.064% of the company's</sdc:value><sdc:value sdc:p="7">common stock outstanding, in</sdc:value><sdc:value sdc:p="8">open market or privately</sdc:value><sdc:value sdc:p="9">negotiated transactions. Based</sdc:value><sdc:value sdc:p="10">on IC's closing stock price of</sdc:value><sdc:value sdc:p="11">$9.72 on August 11, the last</sdc:value><sdc:value sdc:p="12">full trading day prior to the</sdc:value><sdc:value sdc:p="13">announcement of the board's</sdc:value><sdc:value sdc:p="14">approval, the buyback had an</sdc:value><sdc:value sdc:p="15">indicated value of up to $9.72</sdc:value><sdc:value sdc:p="16">mil.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>US - In August 2008, the board of I-Flow Corp (IC), a manufacturer of ambulatory drug delivery systems, authorized the repurchase of up to 1 mil common shares, or about 4.064% of the company's common stock outstanding, in open market or privately negotiated transactions. Based on IC's closing stock price of $9.72 on August 11, the last full trading day prior to the announcement of the board's approval, the buyback had an indicated value of up to $9.72 mil.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">US - In August 2008, the board of I-Flow Corp (IC), a manufacturer of ambulatory drug</sdc:value><sdc:value sdc:p="1">delivery systems, authorized the repurchase of up to 1 mil common shares, or about 4.064%</sdc:value><sdc:value sdc:p="2">of the company's common stock outstanding, in open market or privately negotiated</sdc:value><sdc:value sdc:p="3">transactions. Based on IC's closing stock price of $9.72 on August 11, the last full</sdc:value><sdc:value sdc:p="4">trading day prior to the announcement of the board's approval, the buyback had an</sdc:value><sdc:value sdc:p="5">indicated value of up to $9.72 mil.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value sdc:p="0">US - In August 2008, the board of I-Flow Corp (IC), a manufacturer of ambulatory drug delivery systems, authorized the repurchase of up to 1 mil common shares, or about 4.064% of the company's common</sdc:value><sdc:value sdc:p="1">stock outstanding, in open market or privately negotiated transactions. Based on IC's closing stock price of $9.72 on August 11, the last full trading day prior to the announcement of the board's</sdc:value><sdc:value sdc:p="2">approval, the buyback had an indicated value of up to $9.72 mil.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">US - In August 2008, the board of I-Flow Corp (IC), a manufacturer of ambulatory drug delivery systems, authorized the repurchase of up</sdc:value><sdc:value sdc:p="1">to 1 mil common shares, or about 4.064% of the company's common stock outstanding, in open market or privately negotiated transactions.</sdc:value><sdc:value sdc:p="2">Based on IC's closing stock price of $9.72 on August 11, the last full trading day prior to the announcement of the board's approval, the</sdc:value><sdc:value sdc:p="3">buyback had an indicated value of up to $9.72 mil.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Intended</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>5.40200</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>-6.19600</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>-6.43200</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>-3.78600</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>-11.17300</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>-0.09600</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>132.91600</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>-8.43500</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>-0.37000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.44000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>-0.38000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>-0.83000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>-0.13000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>-0.70000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>132.91600</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>155.57600</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>92.00400</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>70.04900</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>73.21900</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>44.77300</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>-4.16800</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>13.67400</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>-8.40500</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>-17.11000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>-1.82600</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>-15.80800</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>-11.49300</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>-6.93100</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>-7.87800</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>-13.22300</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>-3.32700</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>-18.45700</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>116.47400</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>93.58200</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>100.64400</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>71.14500</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>47.04300</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>126.82400</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>161.12100</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>180.15100</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>97.74000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>82.95300</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>84.43000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>49.33400</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Intended</sdc:value></sdc:q_STATUS><sdc:r_CURR_CODE><sdc:value>US</sdc:value></sdc:r_CURR_CODE><sdc:r_PE><sdc:value>-13.88600</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>nm</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>1.79900</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>1.799</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>7.57700</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>25.43900</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>132.91600</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>47.36800</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>38.23600</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>-28.35500</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>1.79900</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value>3841:Surgical and medical instruments and apparatus</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>131259001</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:upa1_EXCHANGE><sdc:upa1_NATION><sdc:value>United States</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>3841</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>California</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Public</sdc:value></sdc:upa1_STATUS><sdc:upa1_TICKER><sdc:value>IFLO</sdc:value></sdc:upa1_TICKER><sdc:upsic_SIC><sdc:value>3841:Surgical and medical instruments and apparatus</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>131259001</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:upt1_EXCHANGE><sdc:upt1_NATION><sdc:value>United States</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>3841</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>California</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Public</sdc:value></sdc:upt1_STATUS><sdc:upt1_TICKER><sdc:value>IFLO</sdc:value></sdc:upt1_TICKER><sdc:x_RANK1_VALUE><sdc:value>9.72000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>9.72000</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>9.72000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>5.12800</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>Thomson Financial Mergers &amp; Acquisitions</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-27341703</link><guid isPermaLink="false">newstex/BW-0001-27341703</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Aug. ##, #### (Business Wire) --  I-Flow Corporation (NASDAQ:IFLO) announced today that its Board of Directors has authorized the repurchase of up to an additional one million shares of the Company's common stock under the Company's...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016009</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016019</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014018</newstex:cat><pubDate>8/12/2008 8:21:14 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18011000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><title>I-Flow Announces One Million Share Increase in Common Stock Repurchase Plan</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-27341703</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">I FLOW CORP</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">IFLO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-27341704</link><guid isPermaLink="false">newstex/BW-0001-27341704</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Aug. ##, #### (Business Wire) --  I-Flow Corporation (NASDAQ:IFLO) has commenced a lawsuit against Apex Medical Technologies, Inc. and its president, Mark McGlothlin, for infringing I-Flow's United States Patent No. #,###,### and misappropriating...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016031</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014018</newstex:cat><pubDate>8/12/2008 8:21:14 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><title>I-Flow Corporation Enforcing Patent and Trade Secret Rights Against Apex Medical's SOLACE(R) Pump</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-27341704</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">I FLOW CORP</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">IFLO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1915782</link><guid isPermaLink="false">ccbn/T1915782</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by. Welcome to the I-Flow Second Quarter #### Results Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question and answer session. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded, Tuesday, August #, ####. It is now my pleasure to turn the conference over to Mr. Donald Earhart, Chief Executive Officer. Please go ahead, sir. ...

</description><pubDate>8/5/2008 4:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">I-Flow</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">I-Flow Q2 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">IFLO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:00am ET</ccbn:time><title>I-Flow Q2 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1915782</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-27170950</link><guid isPermaLink="false">newstex/BW-0001-27170950</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Aug. #, #### (Business Wire) --  I-FLOW CORPORATION (NASDAQ:IFLO) announced today that total revenue from continuing operations in the second quarter increased ##% to a record $##.# million compared to $##.# million for the same period...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14008000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016027</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07011000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07011001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002004</newstex:cat><pubDate>8/5/2008 8:19:04 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18016000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><title>I-Flow Reports 21% Increase in Total Revenues for the Second Quarter of 2008 to $35.3 Million Versus $29.1 Million for the Second Quarter of 2007</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-27170950</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">I FLOW CORP</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">DONALD M EARHART</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">IFLO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1834045</link><guid isPermaLink="false">ccbn/T1834045</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by and welcome to the I-Flow Corporation first quarter conference call. During the presentation, all participants will be in a listen only mode. Afterwards, we will conduct a question and answer session. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded Friday, May #, ####. I would now like to turn the conference over to Mr. Don Earhart, Chief Executive Officer. Please go ahead, sir. ...

</description><pubDate>5/2/2008 12:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">I-Flow</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 I-Flow Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">IFLO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:00am ET</ccbn:time><title>Q1 2008 I-Flow Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1834045</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1799878</link><guid isPermaLink="false">ccbn/T1799878</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by and welcome to the I-Flow fourth-quarter #### year-end results conference call. During the presentation, all participants will be in a listen-only mode. Afterwards we will conduct a question-and-answer session. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded Tuesday, March ##, ####. I would now like to turn the conference over to Mr. Don Earhart, Chief Executive Officer of I-Flow Corporation. Please go ahead, sir. ...

</description><pubDate>3/18/2008 1:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">I-Flow</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 I-Flow Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">IFLO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:00am ET</ccbn:time><title>Q4 2007 I-Flow Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1799878</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1678586</link><guid isPermaLink="false">ccbn/T1678586</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>11/1/2007 10:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">I-Flow</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q3 2007 I-Flow Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">IFLO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:00am ET</ccbn:time><title>Q3 2007 I-Flow Earnings Conference Call Transcript</title><description>...Ladies and gentlemen, thank you for standing by. Welcome to the I-Flow Third Quarter #### Results Conference Call. During the presentation of all the participants will be in a listen only mode. Afterwards, we will conduct a question and answer session. (Operator Instructions). As a reminder, this conference is being recorded Thursday, November #, ####. I would now like to turn the conference over to Mr. Don Earhart, CEO. Please go ahead, sir. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1678586</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/22865</link><guid isPermaLink="false">srp/22865</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:##### Windrow Drive, Lake Forest, California ##### Incorporated:DelawareWeb Site: www.i-flowcorp.comSIC Classification: Surgical and Medical Instruments and Apparatus (####) Business Description: I-Flow Corporation designs, develops, manufactures and markets technically advanced, low-cost ambulatory drug delivery systems that seek to redefine the standard of care by providing life enhancing, cost effective solutions for pain management and infusion therapy. The company's products are used both in hospitals and other settings, including free-standing surgery centers and physicians' offices. Indices:Russell ####, Russell #### ...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">22865</srp:company><title>I-Flow Corporation</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">449520303</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">IFLO</srp:ticker><pubDate>10/6/2006 12:24:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">22865</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>